4-methyl-piperazine-1-sulfonic acid dimethylamide | 105871-27-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 4-methyl-piperazine-1-sulfonic acid dimethylamide
• 英文别名: 4-Methyl-piperazin-1-sulfonsaeure-dimethylamid；N,N,4-trimethylpiperazine-1-sulfonamide
• CAS: 105871-27-0
• 化学式: C₇H₁₇N₃O₂S
• mdl: MFCD02861215
• 分子量: 207.297
• InChiKey: IKGRULXJLHFPBU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  52.2
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  N-甲基哌嗪 、 二甲胺基磺酰氯 在 氯仿 作用下， 生成 4-methyl-piperazine-1-sulfonic acid dimethylamide
  参考文献：
  名称：

  Morren et al., Bulletin des Societes Chimiques Belges, 1950, vol. 59, p. 228,234

  摘要：

  DOI：

文献信息

• HETEROARYL SULTAM DERIVATIVES AS RORc MODULATORS
  申请人：Genentech, Inc.

  公开号：US20160311817A1

  公开（公告）日：2016-10-27

  Compounds of the formula I or a pharmaceutical salt thereof, wherein m, n, q, r, A, W, X 1 , X 2 , X 3 , X 4 , Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

  式I的化合物或其药用盐，其中m、n、q、r、A、W、X1、X2、X3、X4、Y、Z、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10和R11如本文所定义。还公开了制备这些化合物的方法以及将这些化合物用于治疗炎症性疾病如关节炎的方法。
• Cyanomethyl substituted N-Acyl Tryptamines
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP2020404A1

  公开（公告）日：2009-02-04

  The present invention relates to cyanomethyl substituted N-acyl tryptamines of the formula I in which R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及具有以下结构的氰甲基取代的N-酰基色胺化合物，其中R1、R2、R3、R4、R5、Q、X和W的含义如描述中所定义。根据本发明的化合物是有效的FSH拮抗剂，可用于男性或女性的生育控制，或用于骨质疏松症的预防和/或治疗。
• ARYL SULTAM DERIVATIVES AS RORc MODULATORS
  申请人：Genentech, Inc.

  公开号：US20150197529A1

  公开（公告）日：2015-07-16

  Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, A, W, X 1 , X 2 , X 3 , X 4 , Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

  化合物的公式I：或其药学上可接受的盐，其中m、n、p、q、r、A、W、X1、X2、X3、X4、Y、Z、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11和R12如本文所定义。还公开了制备这些化合物的方法，并将这些化合物用于治疗炎症性疾病如关节炎。
• Alpha-alkyl substituted N-acyltryptophanols
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP2025669A1

  公开（公告）日：2009-02-18

  The present invention relates to α-alkyl substituted N-acyltryptophanols of the formula I in which R1, R2, R3, R4, R5, R6, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及式I的α-烷基取代的N-酰基色氨酸醇，其中R1、R2、R3、R4、R5、R6、Q、X和W的含义如描述中所定义。本发明的化合物是有效的FSH拮抗剂，例如可用于男性或女性的生育控制，或用于骨质疏松的预防和/或治疗。
• SULFONYLTRYPTOPHANOLS
  申请人：WORTMANN Lars

  公开号：US20080255117A1

  公开（公告）日：2008-10-16

  The present invention relates to sulfonyltryptophanols of the general formula I, in which Q, X, W, R1, R2, R3, R4, R5, R6, R7 and R8 have the meaning as defined in the description. The compounds according to the invention are effective FSH receptor antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及通式I的磺酰基色氨酸醇化合物，其中Q，X，W，R1，R2，R3，R4，R5，R6，R7和R8的含义如描述中所定义。本发明的化合物是有效的FSH受体拮抗剂，例如可以用于男性或女性的生育控制，或用于骨质疏松症的预防和/或治疗。